Healthcare Industry News: Dermal Filler
News Release - March 6, 2019
Patricia Altavilla Appointed as Chief Executive Officer at Suneva MedicalCompany Advances into Next Phase of Regenerative Aesthetics with Industry Veteran
SAN DIEGO, March 6, 2019 -- (Healthcare Sales & Marketing Network) -- Suneva® Medical, Inc., privately held aesthetics company, announces Chief Executive Officer, Patricia Altavilla as successor to Preston Romm.
With over 30 years' experience in the aesthetics and medical fields. Altavilla began her career at Mentor Corporation, serving as Vice President of International Sales and Worldwide Marketing. For nearly 20 years, she helped grow the company's sales tenfold, launched new products and enhanced its global market presence by managing international direct and distributor relations. She then went on to be Vice President of Sales, Marketing and Operations at The Plastic Surgery Company, where she co-founded and ran Spa Medicus/Medicus Skin Enhancement for several years. Soon after, she joined BioForm Medical, now part of Merz Aesthetics, as the Vice President of Global Marketing, and was instrumental in restructuring the marketing department, growing sales, creating a practice development program and raising the company's overall visibility in the marketplace that resulted in an acquisition by Merz Aesthetics. Altavilla also held numerous leadership roles at medical technology company ZELTIQ® Aesthetics Inc.
Throughout her career she has been instrumental in developing global marketing strategies, building physician loyalty, enhancing practice development, launching innovative products, and increasing the company's industry presence. She has consistently led negotiations for joint ventures, strategic partnerships and distribution relationships in an effort to continue to advance the companies' positions in the market place.
"As we redefine Suneva Medical's position within the industry as leaders in Regenerative Aesthetics, I am honored to help pave the way for the company, further shaping the future of our brand," said Altavilla. "With our introduction of two new products and continuing to build the success of our flagship product Bellafill, it is an exciting time for Suneva Medical."
About Suneva Medical, Inc.
Suneva Medical is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only Dermal Filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years old. The company markets Bellafill® in the U.S., Canada, Hong Kong, Korea and Mexico. For more information, visit www.sunevamedical.com.
Source: Suneva Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.